Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...

When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

The SAIR database is designed to help scientists train AI models to better predict protein-ligand binding affinities for drug ...

The company has integrated the AI model into its internal discovery pipeline and aims to use it in collaborative drug ...

Velsera’s technology enables compliant access to sensitive datasets while keeping data within the control of its source ...

EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...